Precigen, Inc. (PGEN)
7.48
-0.18
(-2.35%)
USD |
NASDAQ |
Oct 13, 16:00
7.485
0.00 (0.00%)
After-Hours: 20:00
Precigen EPS Diluted (TTM) : -1.100 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.100 |
| March 31, 2026 | -1.238 |
| December 31, 2025 | -1.400 |
| September 30, 2025 | -1.401 |
| June 30, 2025 | -0.4285 |
| March 31, 2025 | -0.5716 |
| December 31, 2024 | -0.4825 |
| September 30, 2024 | -0.5479 |
| June 30, 2024 | -0.5406 |
| March 31, 2024 | -0.3895 |
| December 31, 2023 | -0.3932 |
| September 30, 2023 | -0.3669 |
| June 30, 2023 | -0.3238 |
| March 31, 2023 | -0.3299 |
| December 31, 2022 | -0.3274 |
| September 30, 2022 | -0.342 |
| June 30, 2022 | -0.4549 |
| March 31, 2022 | -0.4676 |
| December 31, 2021 | -0.4607 |
| September 30, 2021 | -0.5734 |
| June 30, 2021 | -0.6023 |
| March 31, 2021 | -0.7658 |
| December 31, 2020 | -1.030 |
| September 30, 2020 | -1.886 |
| June 30, 2020 | -2.055 |
| Date | Value |
|---|---|
| March 31, 2020 | -2.042 |
| December 31, 2019 | -2.086 |
| September 30, 2019 | -3.584 |
| June 30, 2019 | -3.68 |
| March 31, 2019 | -3.938 |
| December 31, 2018 | -3.871 |
| September 30, 2018 | -1.513 |
| June 30, 2018 | -1.40 |
| March 31, 2018 | -1.05 |
| December 31, 2017 | -0.98 |
| September 30, 2017 | -1.12 |
| June 30, 2017 | -1.03 |
| March 31, 2017 | -1.29 |
| December 31, 2016 | -1.58 |
| September 30, 2016 | -1.49 |
| June 30, 2016 | -1.59 |
| March 31, 2016 | -1.54 |
| December 31, 2015 | -0.74 |
| September 30, 2015 | -0.28 |
| June 30, 2015 | -0.47 |
| March 31, 2015 | -0.63 |
| December 31, 2014 | -0.84 |
| September 30, 2014 | -1.15 |
| June 30, 2014 | -0.47 |
| March 31, 2014 | -2.40 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Anika Therapeutics, Inc. | -0.2741 |
| Aldeyra Therapeutics, Inc. | -0.3829 |
| Repligen Corp. | 0.7337 |
| AC Immune SA | -0.556 |
| Amgen, Inc. | 16.10 |